title: Inclusion of glucocorticoids in recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis: Comment on the article by Saag et al.
authors.forename: L H D
authors.initials: LH
authors.lastname: van Tuyl
authors.forename: W F
authors.initials: WF
authors.lastname: Lems
authors.forename: A E
authors.initials: AE
authors.lastname: Voskuyl
authors.forename: B A C
authors.initials: BA
authors.lastname: Dijkmans
authors.forename: M
authors.initials: M
authors.lastname: Boers
authors.forename: P J S M
authors.initials: PJ
authors.lastname: Kerstens
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000627:therapeutic use*; D006287:Health Planning Guidelines; D006801:Humans; D014481:United States
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D018501:Antirheumatic Agents; D005938:Glucocorticoids